Table 7.
Compound | B/Pa | Haematocrit (Gender) |
---|---|---|
Ionized or partially ionized bases at physiological pH | ||
Cycloguanil | 0.71 ± 0.07 | 0.48 (M) |
Doxycyclin | 0.78 ± 0.06 | 0.43 (M) |
Pyronaridine | 9.0 ± 0.83 | 0.48 (M) |
Proguanil | 3.30 ± 0.14 | 0.46 (M) |
Primaquine | 0.82 ± 0.07 | 0.44 (M) |
Chloroquine | 3.5 ± 0.09 | 0.42 (F) |
Chlorproguanil | 3.3 ± 0.38 | 0.43 (M) |
Azithromycin | 1.6 ± 0.19 | 0.48 (M) |
AQ-13 | 3.15 ± 0.20 | 0.42 (M) |
Desethylamodiaquine | 3.26 ± 0.35 | 0.50 (M) |
Quinine | 0.67 ± 0.02 | 0.44 (M) |
Clindamycin | 0.61 ± 0.04 | 0.42 (M) |
KAF156 | 1.3 ± 0.02 | 0.42 (F) |
M5717 | 1.3 ± 0.02 | 0.42 (F) |
OZ277 | 1.10 ± 0.10 | 0.46 (M) |
Mefloquine | 1.1 ± 0.07 | ~ 0.43 (M) |
Amodiaquine | 1.1 ± 0.18 | ~ 0.43 (M) |
NPC1161B | 1.09 ± 0.07 | 0.44 (M) |
Ferroquine | 1.6 ± 0.15 | ~ 0.43 (M) |
Naphthoquine | 1.14 ± 0.10 | ~ 0.43 (M) |
Tafenoquine | 1.3 ± 0.04 | ~ 0.43 (M) |
MMV253 | 1.0 ± 0.05 | ~ 0.43 (M) |
MMV052 | 1.6 ± 0.14 | ~ 0.43 (M) |
Piperaquine | 0.57 ± 0.05 | ~ 0.43 (M) |
Halofantrine | 0.68 ± 0.06 | 0.43 (M) |
TDD-E209 | 0.51 ± 0.08 | 0.44 (M) |
Lumefantrine | 0.48 ± 0.09 | 0.48 (M) |
Ionized acids at physiological pH | ||
Sulfadoxine | 0.57 ± 0.03 | 0.46 (M) |
Sulfamethoxazole | 0.65 ± 0.07 | 0.43 (M) |
Artesunate | CNDb | 0.44 (M) |
Atovaquone | 0.52 ± 0.03 | 0.44 (M) |
Zwitterionic or partially zwitterionic at physiological pH | ||
P218 | 0.56 ± 0.03 | ~ 0.43 (M) |
JPC3210 | 0.54 ± 0.04 | ~ 0.43 (M) |
Neutral at physiological pH | ||
Dapsone | 1.1 ± 0.06 | 0.43 (M) |
Dihydroartemisinin | CNDb | 0.42 (M) |
DSM421 | 0.53 ± 0.03 | 0.44 (M) |
Pyrimethamine | 0.84 ± 0.03 | 0.43 (M) |
MMV048 | 0.77 ± 0.03 | 0.42 (F) |
Artemisone | CNDb | 0.44 (M) |
Artemether | CNDb | 0.42 (M) |
SJ733 | 0.72 ± 0.02 | 0.42 (F) |
DSM265 | 0.54 ± 0.02 | 0.44 (M) |
KAE609 | 0.66 ± 0.04 | 0.42 (F) |
OZ439 | 0.78 ± 0.05 | 0.44 (M) |
ELQ300 | 0.53 ± 0.05 | 0.44 (M) |
aMean ± SD, n = 3–4 measurements
bCND = could not determine, unstable in blood and plasma